Global Generic And Biosimilar Pharmaceuticals Market Report

The Plimsoll Analysis will give you a completely new insight into the performance, financial health and value of the 1144 leading Generic and Biosimilar Pharmaceuticals (Global) companies. You will receive an up to date opinion on each company showing those in difficulty, the fastest growing, the best takeover targets and much more. The latest analysis will show you:

• 234 companies are in danger
• 84 companies are attractive for takeover
• 120 companies are making a loss
• 100 companies lose over a quarter of their value

What else will a Plimsoll Analysis show you?

The Plimsoll Analysis has been used by directors and senior decision makers for almost three decades to give them the intelligence they need to make sense of the markets they operate in. Based on the latest company data possible, it will let you:

• See how your own company compares to others
• Pick out the latest exciting acquisition prospects
• Be alerted to companies that pose a threat
• Get early warning of companies heading for failure
• Spot exceptional performers in your market
• Share the analysis with 5 colleagues

Plimsoll have a marvellous ability to gather relevant financial data on companies and present it in a clear, helpful way.

John Priestland, Global Strategy Director, WSP Global

Want a demo of the Plimsoll Analysis? Call +44 (0)1642 626 441 today